Blocknomi
Key Highlights Merck shares soar 12.12% following breakthrough Phase 3 melanoma study success. Positive Phase 3 data released by Merck and Moderna for melanoma combination therapy. Combination of intismeran and…
Related articles
-
HYPE Skyrockets Past $70 as Trump Reveals CFTC Push for Hyperliquid’s US Entry
CryptoPotato Published 19.08.2026 19:41
-
INVO Fertility (IVF) Stock Skyrockets 145% Following Stellar Q2 Earnings Performance
Blocknomi Published 17.08.2026 14:16
-
XRP Ledger Partial Payments Are Not a Bug: What New Users Need to Know
U.Today Published 05.08.2026 13:00
-
Top Solana (SOL) Price Predictions as of Late
CryptoPotato Published 05.08.2026 19:29
-
Bitcoin Price Analysis: Will BTC Break Above $66K or Fall Below $62K Next?
CryptoPotato Published 04.08.2026 14:18
-
Disney Stock Extends Rally as New Avengers Doomsday Trailer Drops
BeInCrypto Published 15.08.2026 10:52
-
CoinRabbit and ChangeNOW Publish a Report on Financial Privacy in Digital Assets
Crypto Daily Published 05.08.2026 16:05
-
Sunrise Energy Metals (SRL) Stock Jumps 16% After Securing $400M Pentagon Financing
Blocknomi Published 10.08.2026 13:59